Posts Tagged ‘side effects’

Record Breaking $327 Million Verdict Upheld Against Manufacturer of Antipsychotic Risperdal—Request for New Trial Denied

Wednesday, December 21st, 2011

PR Newswire – December 21, 2011

(Click image for international warnings on antipsychotic drugs) The "dear doctor" letter, sent to more than 7,000 doctors across South Carolina, and the package insert were found to be misleading about the safety and effectiveness of the antipsychotic drug Risperdal.

The jury verdict in the case of State of South Carolina versus Ortho-McNeil-Janssen Pharmaceuticals and Johnson & Johnson, Inc. has been upheld and requests for a new trial denied, affirming groundbreaking $327 million in civil penalties against the manufacturers of the drug Risperdal.

Circuit Court Judge Roger Couch announced the rulings on December 20 through two written orders. One order denies the defendant’s motion for judgment notwithstanding the verdict or, in the alternative, for a new trial; the second order denies the defendant’s motion to alter or amend the judgment and/or for a new trial. John B. White, Jr. and Donald C. Coggins, Jr. of Harrison, White, Smith & Coggins, P.C., a Spartanburg-based law firm, along with John Simmons of the Simmons Law Firm, a Columbia-based law firm, and Bailey Perrin Bailey, a Texas based law firm represented South Carolina in the case.

“We are obviously very pleased with Judge Couch’s decision and his careful consideration of this matter,” stated John B. White, Jr. one of the attorneys representing the state in the case. “The verdict handed down by the jury is just and speaks the truth. The damages awarded further substantiated the level of deception Janssen used in business practices in our state. Once again, we have sent a clear message to drug companies that deceptive business practices will not be tolerated in South Carolina.”

On March 22, 2011 a jury in the Spartanburg Court of Common Pleas found that New Jersey-based Janssen willfully violated the South Carolina Unfair Trade Practices Act by engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce in the “dear doctor” letter of November 10, 2003 and the drug label (package insert). This decision represents the first jury verdict that finds the defendant violated unfair trade practices since the inception of its pharmaceutical product. The “dear doctor” letter, sent to more than 7,000 doctors across South Carolina, and the package insert were found to be misleading about the safety and effectiveness of the antipsychotic drug Risperdal. Risperdal was introduced by Janssen in 1994 and by 2005, generated annual revenues in excess of $3.5 billion.

On June 3, 2011 civil penalties amounting to $327,073,700 were ordered by Circuit Court Judge Roger Couch based upon violations found with the drug labels and “dear doctor” letters. Regarding the drug label violations, the judge ruled that 509,499 package inserts were distributed with sample boxes, and levied $300 per violation for a total drug label awarded damages of $152,849,700. Regarding the “dear doctor” letter violations, the judge ruled that 7,184 letters were mailed and 36,372 were provided during sales calls, and levied $4000 per violation for a total “dear doctor” letter awarded damages of $174,224,000.

The combination of the drug label and letter damages of $327,073,700 amounts to the highest verdict brought against Janssen for the drug Risperdal.

http://www.marketwatch.com/story/record-breaking-327-million-verdict-upheld-in-janssen-case-and-request-for-new-trial-denied-2011-12-21

« Return to news items


Share

Can Prozac Cause Kids to Kill? A Canadian Judge Has Ruled it Can

Wednesday, December 7th, 2011

Note from CCHR:

(see videos at the bottom of this post from film maker Michael Moore and Fox National News reporter Douglas Kennedy)

It is well documented that psychiatric drugs, particularly antidepressants, can cause a host of violent side effects including mania, psychosis, aggression, violence and in the case of the antidepressant Effexor, homicidal ideation.   As far back as 1991, CCHR helped organize dozens of individuals and experts testifying before the US FDA that people with no prior history of violence (or suicide) became homicidal and suicidal under the influence of antidepressants (see CCHR’s exclusive footage of the 1991 hearings here).  It would take the FDA another 13 years to admit antidepressants could cause suicide and black box warnings were finally issued in 2004.  However, despite all the documented violence-inducing side effects of these drugs, the FDA has never issued black box warnings on antidepressants causing violence or homicide despite the fact that at least 11 recent school shootings were committed by kids documented to be on or in withdrawal from psychiatric drugs (see Fox News special report on school shootings here).   Therefore, the case cited below, where a Canadian judge ruled that a teenage boy murdered his friend due to being on the antidepressant Prozac, and the fact that the case will not be appealed, is a major turning point in exposing the violence inducing effects of antidepressant drugs.  

National Post
By Tom Blackwell
December 7, 2011

JB Reed/Bloomberg News

A Winnipeg judge’s ruling that a teenage boy murdered his friend because of the effects of Prozac will not be appealed, confirming an apparent North American first and reviving debate around the widespread prescription of anti-depressants to young people.

Justice Robert Heinrichs concluded the 15-year-old boy was under the influence of the medication when he thrust a nine-inch kitchen knife into the chest of Seth Ottenbreit, a close friend.

Although the killer pleaded guilty to second-degree murder, the judge cited the drug’s alleged side effects as a reason not to raise the case to adult court, and to mete out a sentence last month of just 10 months – on top of two years already spent in jail.

A spokeswoman for the Manitoba Justice Department said this week prosecutors have decided not to appeal the provincial-court decisions, which were earlier met with outrage from Mr. Ottenbreit’s family and friends.

Both the boy’s lawyer and the psychiatrist who testified on his behalf say it is the first time a criminal-court judge in North America has made such a finding.

Prozac is meant to curb the effects of depression, but Justice Heinrich concluded it set off a steady deterioration in the young murderer’s behaviour.

“He had become irritable, restless, agitated, aggressive and unclear in his thinking,” the judge said. “It was while in that state he overreacted in an impulsive, explosive and violent way. Now that his body and mind are free and clear of any effects of Prozac, he is simply not the same youth in behaviour or character.”

Yet the empirical underpinning of his conclusion, and the pros and cons of young people taking Prozac and other “selective serotonin reuptake inhibitor (SSRI)” anti-depressants, seem less clear-cut.

Justice Heinrichs relied largely on the expert testimony of Dr. Peter Breggin, a controversial American physician known for his outspoken opposition to the use of virtually any psychiatric drug. Some other experts say scientific evidence of a link between the latest anti-depressants and homicide is thin.

“I think it got pulled out of a hat, frankly,” said Dr. Umesh Jain, a child and adolescent psychiatrist at Toronto’s Centre for Addiction and Mental health. “You could construct a weak and biologically plausible effect, but you’d have to be pretty convincing in court.”

Studies have established such drugs can increase the risk of young patients having suicidal thoughts. Their tendency to lift inhibition could also release some hostility or violence lurking in a person’s character, said Dr. Jain. Small studies like one he co-authored in 1992 have also suggested that the drugs can trigger short-term mania, especially in bi-polar disorder patients.

There is little or no scientific evidence directly linking the anti-depressants and serious violence or homicide, though, he said.

Still, the official “product monograph” approved by Health Canada for Prozac says the drugs are not recommended for use on adolescents, and warns that agitation, hostility and aggression might ensue. Doctors are allowed to prescribe medications “off label” to patients even when the approval does not expressly permit it.

Specialists in Winnipeg responded to concerns voiced by the accused’s parents by actually increasing the dose, said Greg Brodsky, the teenager’s lawyer.

“On Prozac he was becoming more irrational and aggressive,” Mr. Brodsky said. “That should have been a warning. That warning wasn’t heeded.”

SSRI drugs have a contentious track record. They were hailed originally as a safe alternative to older anti-depressants, then clinical-trial results came to light in 2004 that suggested they increased the risk of children and adolescents having suicidal thoughts.

Other studies have indicated they are effective in patients with major depression, but little better than a placebo for mild to moderate cases.

The Winnipeg murderer had a history of smoking marijuana, had abused prescription drugs and “experimented” with cocaine, but was trying to break free of that background when a family doctor prescribed Prozac for depression in July, 2009.

On Sept. 20, the accused met with Mr. Ottenbreit and another friend at his house, after the two friends had earlier stormed into his home, allegedly damaging the floor. The killer and Mr. Ottenbreit shared a cigarette, before the accused pulled aside a sweater on the floor of his garage, revealing the knife. He picked it up, “got this weird look on his face,” then abruptly stabbed his friend, the other boy told police.

“They were in my house, they dented the floor, I had nothing else to do but to stab him,” he told police later.

Dr. Keith Hildahl, clinical head of Winnipeg’s Child and Adolescent Mental Health program, testified that the Prozac might have played a role, but concluded on balance that his behaviour that summer was largely a result of the tense relationship he had with his parents.

Dr. Breggin, who has testified in a number of U.S. cases where anti-depressants allegedly led to murder or other violence and reviewed the Winnipeg case, pointed the finger of blame at the medication.

“These drugs produce a stimulant or activation continuum,” he said in an interview. “That continuum includes aggression, hostility, loss of impulse control … all of which are a prescription for violence.”

Dr. Breggin’s long-standing criticism of psychiatric drugs and opposition to the view that psychiatric problems have biochemical roots have prompted some supporters to call him the “conscience” of the speciality, and some psychiatrists and patient advocates to condemn him as a harmful influence.

Read article here:  http://news.nationalpost.com/2011/12/07/prozac-defence-stands-in-manitoba-teens-murder-case/

See Michael Moore discuss the need for an investigation into psychiatric drugs causing violence:

See Fox National News on School Shootings and Psychiatric Drugs:

To read international warnings and studies on psychiatric drugs causing violence – visit CCHRInt’s Psychiatric Drug database and simply type in keywords such as violence, mania, psychosis, aggression in the red search box

« Return to news items


Share

ONE DRUG TO MAKE YOU HAPPY

Monday, November 28th, 2011

NewsWithViews.com – 11/28/2011
by Jonathan Emord, Constitutional Attorney and Author

Psychiatric drugs are big sellers. They are among the best selling drugs made. In 2010, Americans or their insurers doled out some $16.1 billion for anti-psychotics; $11.6 billion for anti-depressants; and $7.2 billion for ADHD treatments.

Within the last two decades the field of psychiatry has mushroomed from a fringe body of Sigmund Freud admirers to a mainstream player in the field of medical pharmacology, largely because of an unseemly union between that profession and the drug industry, leading to the creation of many never before known disease states and profitable ways to exploit those alleged diseases with psychiatric services and drugs.

The field of psychiatry has persistent and well-informed critics who point to the excessive drugging of institutionalized patients, of children commonly misdiagnosed as suffering from Attention Deficit Disorder or Attention Deficit Hyperactivity Disorder, and of the elderly misdiagnosed with treatable dementia, among others. The drugs given these patients have their own side-effects, including increased risk of depression, suicidal thoughts, birth defects, and even death. Because of the movement of psychiatry from the fringe of medicine to its heart, a majority of Americans are likely to come into contact with psychiatric drugs, either recommended for use by their children or for use by them at some point in their lives. Indeed, presently some 1 in 5 adults take anti-depressants, anti-psychotic, or anti-anxiety drugs.

The next edition of the American Psychiatric Association’s Diagnostic and Statistical Manual (DSM-5), the profession’s so-called diagnostic bible, will soon be published in 2013. It comntinues the trend of identifying as “diseases” conditions that have previously been considered within the normal range. It adds to the list of “disease” states “apathy syndrome” (i.e., not caring enough); “internet addiction disorder” (i.e., liking the web too much); “parental alienation syndrome” (i.e., not liking your parents enough); “mild neurocognitive disorder” (i.e., age-related decline in mental function); “absexual” disorder (i.e., disliking sex); and “sluggish cognitive tempo” (i.e., daydreaming too much). Characteristics that we all used to think within the realm of normal brain function (such as teenage angst at parental rules; parental angst at teenage rebellion; a loss of quick wittedness in the elderly; youthful exuberance or youthful preoccupation with daydreams beyond the confines of academia) are all fast becoming “diseases.” The APA’s overall movement has been one of calling into question characteristics of eccentricity, leading to an unscientific conclusion that anything different may be rightly called a disease and rightly prescribed a treatment.

Every newly identified psychiatric disorder begets a new slate of psychiatric drugs for their treatment, giving leading pharmaceutical companies new opportunities to profit from the expansion of psychiatric diagnoses.

Psychiatric drugs are big sellers. They are among the best selling drugs made.

In 2010, Americans or their insurers doled out some $16.1 billion for anti-psychotics;

$11.6 billion for anti-depressants;

and $7.2 billion for ADHD treatments.

Profit lies in designing drugs for the treatment of these conditions. As the drug industry continues to pump out new elixirs that, in turn, leads to more reliance on psychologists and psychiatrists, which leads them in turn to prefer identifying more conditions as disease. The perverse incentives abound, and the FDA is pleased to approve the drugs at the behest of the drug company sponsors.
Everyone standing to profit from the sale of these agents wins at the expense of patients.

The drugging of America is an enormous problem, having spill-over effects that include drug addiction and destruction of the family, productivity, even national security. With an ever rising population taking these drugs which alter cognitive function, it becomes ever more apparent that the very fabric of our society, its common commitment to stable family life, self-sacrifice for the greater good, and adherence to laws that protect life, liberty, and property are all imperiled. As the drug industry and psychiatric profession profits enormously with each new declared disease state, there is a loss of free agency in the population, a movement that saps self-control from the individual in favor of control by the medical community over basic life-affecting decisions. Patients become dependent, event addicted, to drugs, and ever more dependent on their medical counselors to cope with life.

Whatever may be said for use of psychiatric drugs in those who cannot function in society, the expansion of those drugs to embrace those who can, including those with virtually any characteristic that exceeds the norm, represents a horrific sacrifice of the very promise of life that lies in those eccentricities. It is particularly horrific to watch beautiful, energetic children with all their great promise become addicted to drugs that alter brain chemistry in ways that yield drug dependency and lessen their perception of and enthusiasm for life and their ability to achieve. A majority of children prescribed anti-depressant and anti-psychotic drugs are wrongly prescribed those drugs, even by accepted psychiatric standards. That misguided course is itself a form of deviant behavior by this profession, calling into question the mental stability of those who would profit off of misdiagnosis and mistreatment.

The psychiatric drugging of America is bearing and will continue to bear for generations to come toxic consequences, whether in the form of the destruction of the family, increases in crime, or decreases in productivity and inventiveness. It’s high time for a rebellion against this drugging for the sake of sanity.

http://www.newswithviews.com/Emord/jonathan220.htm

Jonathan W. Emord is an attorney who practices constitutional and administrative law before the federal courts and agencies. Congressman Ron Paul calls Jonathan “a hero of the health freedom revolution” and says “all freedom-loving Americans are in [his] debt . . . for his courtroom [victories] on behalf of health freedom.” He has defeated the FDA in federal court a remarkable eight times, six on First Amendment grounds, and is the author of Amazon bestsellers The Rise of Tyranny, and Global Censorship of Health Information. He is also the American Justice columnist for U.S.A. Today Magazine. For more info visit Emord.com.

« Return to news items


Share

Georgia Advocate Speaks Out Against Psychiatric Medication Use in Nation’s Foster Care System

Tuesday, November 1st, 2011

Juvenile Justice Information Exchange
By James Swift
October 28, 2011

Giovan Bazan, 21, speaks at the 11th annual CHRIS KIDS fundraiser in September, 2011. Atlanta, Ga.

Alongside photographs of rocker Jon Bon Jovi and Atlanta Mayor Kasim Reed, Giovan Bazan looks downright blithe. Although they tower over him, the tuxedo-clad Bazan wearing a slight smirk, his gelled hair and pierced ears sharply contrasting his suit-and-tie apparel.

With his cheery disposition, you wouldn’t suspect Bazan had a troubled childhood. In reality, the 21-year-old has spent a majority of his life in foster homes, and for most of his childhood, he was prescribed anti-depressants and behavioral disorder drugs.

“I went into foster care at 11 months old,” the Los Angeles native said. “When I was six, they put me on medication.”

By many accounts Bazan has come a long way since his days in foster care. In September he spoke at Atlanta-based CHRIS KIDS‘ 11th annual fundraiser alongside towering protraits of celebrities. He has adressed state legislature multiple times about issues pressing foster youth in the state. He has managed to turn his troubled childhood into a stepping stone, not a crux.

Kathy Colbenson, CEO of CHRIS KIDS and co-organizer of the fundraiser, said Bazan’s combination of determination, will and outlook has set a tremendous example for children around the nation facing similar circumstances.

“I think what he’s doing is awesome,” she said.

Today Bazan holds a number of titles. He is the JUSTGeorgia project coordinator for EmpowerMEnt, an initiative of Multi-Agency Alliance for Children, Inc. that is designed to help at-risk youth within the state. He also serves as a Youth Support Specialist Georgia Department of Family and Children Services, a liaison for the White House Council for Community Solutions, and as owner and CEO of the National Executive Protection Agency.

“It’s a travesty how frequently kids in the foster care system are medicated, and I feel like my foster mom wanted to keep me medicated,” Bazan said. “When they put me on medication, when they started to sedate me, it abused my emotions and controlled my mind to the point where I went from being a child to being nothing short of a vegetable.”

Click image to watch video with Giovan Bazan

Bazan started receiving psychotropic medication following the death of one of his foster mothers, he said.

“Mommy Karen was very caring, she was very supportive, very loving,” he said, recalling her life. “If I scratched a knee, she would be there to hold me.”

Bazan remembered taking cross-country road trips from California to South Carolina. But he didn’t know the “vacations” were actually for his foster mother to receive chemotherapy treatments. She died of cancer when he was just four-years-old, he said.

After her death, Bazan was taken in by a foster mother that he claimed was vindictive and hostile toward him.

“She was always angry about something that I did,” Bazan said. “I always felt that, for some reason, she always resented me.”

Bazan began receiving behavioral treatment drugs shortly after, he said.

“It started with Ritalin,” Bazan said. Soon after he was prescribed, what he called, a “cocktail of medication” by psychiatrists – primarily anti-depressant drugs.

“That little childhood personality that kids have was void,” Bazan said about his experiences in elementary school. “I would come to class and just put my head down and not talk to my classmates. I couldn’t explain it, I didn’t know what was going on.”

Originally he was medicated for displaying symptoms of Attention Deficit Disorder, he said.

“When I was medicated, it was to eradicate a specific problem, which was [being] overactive and hyper,” Bazan said. “In other words, being a child. They medicated me to prevent me from being a child.”

Bazan said it was too much, considering himself overmedicated as a child.

“As time progressed, the dosage of the medication would have to increase because my body would adjust to the medication,” he said. “This medication that they would give me had so many side effects that they would have to counter those side effects with more medication.”

As a child, Bazan said, he was given experimental dosages of psychotropic medication. In elementary school, he said, he received treatment doses that were equivalent to those given to teenagers and young adults.

“Ultimately, that’s what they were doing … they were testing on me,” he said. “I was having seizures, I would have horrendous nosebleeds. It was more detrimental than it was helpful.”

In 2010, the Tufts Clinical and Translational Science Institute released a report showing that overmedication within the foster care system was indeed a problem. About 52 percent of kids in the system had been prescribed psychotropic medication. Bazan found the findings both alarming and horrifying.

“One of the biggest changes that we’re looking to in the future deals with regulating psychotropic medication being administered to foster care children,” he said. “They’re being medicated because they’re coming from abusive homes, when what really happens is the system tends to look at a case and say ‘oh, well they’re having trouble paying attention.’ Well, yeah, they’re having trouble paying attention in school because they’re getting beat up at home and they’re being abused at home. Whatever stress a normal kid has, theirs is exponentially multiplied.”

In 2011, Georgia legislators introduced House Bill 23 (HB 23), a bill aimed at regulating and monitoring psychotropic drug prescriptions within the foster care system. But the bill, also known as the ”Foster Children’s Psychotropic Medication Monitoring Act,” never made it into law.

Bazan said anyone that doesn’t see the dangers of overprescribing psychiatric drugs, to kids or to anyone, should try taking them for themselves.

“Take it for a couple of years,” he said. “That’s what happens to the foster kids. They’re not given medication for a couple of months, and bam, the problem’s solved. Psychotropic medication isn’t designed to be taken like antibiotics, where you can take them for a certain amount of time and the problem is eliminated. You have to take a higher dosage, and you have to take a higher dosage and when it no longer affects you, you have to switch to a more powerful medication.”

According to Bazan, behavioral drugs and other forms of psychiatric medicine pose an imminent threat to kids in Georgia foster care and throughout the nation.

“If you can find valid proof that [discredits] what evidence has shown over and over again that it is harmful to youth, then by all means, let me know,” he said. “But you won’t find that evidence outside of pharmaceutical companies, who push that kind of information out there.”

Read article here:  http://jjie.org/georgia-advocate-speaks-out-against-psychiatric-medication-use-nations-foster-care-system/52283

« Return to news items


Share

With growing public awareness of antidepressant risks: Pro-pill website Web MD does damage control

Monday, October 24th, 2011

OpEdNews – October 24, 2011

by Martha Rosenberg

WebMD, the gigantic, pro-pill web site whose original partner was Eli Lilly, is doing damage control for SSRI antidepressants.

There was a day when it seemed like everyone was on antidepressant “happy pills” like Prozac, Paxil and Zoloft. But then the pendulum began to swing. Patients objected to the weight gain and feelings of not being “themselves,” sexual side effects and the withdrawal symptoms. There were even reports and warnings about suicide and other “neuropsychiatric” effects.

Now, WebMD, the gigantic, pro-pill web site whose original partner was Eli Lilly, is doing damage control for SSRI antidepressants. New articles, sounding like they’re from crib makers or cantaloupe growers, urge patients not to panic or quit taking their pills just because of things they read.

Don’t believe all the hooey about antidepressants turning “you into a zombie,” ruining your sex life or costing too much, says an article called Fears and Facts About Antidepressants on WedMD. And don’t be impatient!   “ If the first antidepressant medication doesn’t help, the second or third often will . Most people eventually find one that works for them.” Ka-ching.   Don’t listen to all that suicide talk either!   “Switching to a different antidepressant may help,” say the damage control articles.

Is your fear of becoming a drug lifer keeping you from antidepressants, asks another WebMD article called What’s Stopping You from Seeing a Doctor About Depression? “If you do need a medication, it most likely won’t be for life,” says the article. Just until the patent runs out?

Do you think you can ignore your depression and it will go away?   “Waiting for depression to simply pass can be harmful,” because “depression that goes untreated may become more severe,” say the WebMD articles–rewriting medical practice itself since depression has never been a progressive disease but is actually self limiting.

The important thing, say the articles, is to never stop your meds. “Stopping medication abruptly may.. cause depression to return,” and can cause side effects, say the articles. Worse–”prescription abandonment”–people who discover what a drug costs and leave it at the pharmacy or quit drugs because of their effects– costs Pharma lots of money! Pharma even has programs now that send Big Brother nurses to people’s homes, through their pharmacies, to make sure people are taking their meds.

 One antidepressant with a big PR problem is Eli Lilly’s Cymbalta. It’s linked to the deaths of   Traci Johnson, a healthy 19-year-old who hung herself on the Lilly campus during clinical trials in 2004, and Carol Anne Gotbaum, daughter-in-law of former New York City Public Advocate Betsy Gotbaum who died in police custody at Phoenix’s Sky Harbor airport in 2007.

Cymbalta is noted in the scientific literature for producing suicidal side effects in people with no mental health history. A 37-year-old man described in the Journal of Clinical Psychopharmacology with a stable marriage and employment and no history of mental problems tried to kill himself with carbon monoxide two months after taking Cymbalta for back pain. A 63-year-old man, also with no mental health history, became suicidal on the drug after two weeks.

“There is an emergence of suicidality in apparently nonsuicidal patients after starting or increasing Duloxetine [Cymbalta] reads an article in Clinical Practice and Epidemiology in Mental Health.”

But now, Cymbalta is being promoted as a pain drug of choice like it’s not a repurposed antidepressant with antidepressant side effects. Last year it was approved for chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain, and it was already approved for fibromyalgia and diabetic nerve pain.

A Cymbalta ad in October’s New England Journal of Medicine , says “Today a non-NSAID [non- aspirin or ibuprofen] non-narcotic, once daily analgesic FDA approved for 3 indications across 4 different chronic pain conditions can be found in 1 med.” Sounds as safe Vioxx.

http://www.opednews.com/articles/Should-You-Take-A-Psychiat-by-Martha-Rosenberg-111023-164.html

Martha Rosenberg’s first book , Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, will be published by Prometheus Books in 2012.

« Return to news items


Share

Shy children now candidates for dangerous psychiatric drugs

Wednesday, October 5th, 2011

NaturalNews
By Elizabeth Walling
October 5, 2011

(NaturalNews) New guidelines for mental illness turn shyness in children from a personality trait into a mental disorder that warrants drug treatment. Drug companies already target children, who fidget too much in class or have trouble concentrating on their homework, with stimulant drugs for treating attention deficit disorder. Now children who sit too quietly or are more withdrawn than their peers will also be targeted with medication for social anxiety disorder or depression.

These new guidelines increase the likelihood that children, who tend to be quiet or sad, will be diagnosed with depression. And children who talk back to adults or lose their temper frequently may be diagnosed with what is called oppositional defiant disorder. A diagnose in either case will likely lead to treatment with powerful psychotropic drugs.

Serious Risks for Children who take Psychiatric Drugs

The idea of turning every spectrum of human emotion into some kind of mental disorder is not only absurd, but it also threatens the long-term mental and physical health of our children.

Millions of children are currently taking one or more behavior-altering medications, despite the fact that these drugs carry the risk of serious side effects. Some of these side effects include suicidal thinking, loss of appetite, nausea, insomnia, sedation, seizures, insulin resistance, acne, tremors, muscle stiffness and more.

Some psychologists also point out that simply drugging children for behaving out of the norm could actually be masking very serious underlying problems. Children, who are the victims of mental, physical or sexual abuse, will often exhibit behaviors such as shyness, sadness or being more withdrawn. These experts warn that trying to seek a quick-fix for negative emotions denies children what they truly need: long-term care and guidance.

Who stands to profit from expanding the guidelines for diagnosable mental disorders? The answer is quite simple: the pharmaceutical companies which manufacture the drugs for treating these conditions. However, when we start labeling children as disordered for simply being quieter than their peers or having an occasional angry outburst, we are stepping into dangerous territory that threatens the future of an entire generation and beyond.

Sources for this article include:

http://www.dailymail.co.uk/health/a…

http://www.telegraph.co.uk/health/h…

http://www.sciencedaily.com/release…

http://www.aboutourkids.org/article…

About the author:

Elizabeth Walling is a freelance writer specializing in health and family nutrition. She is a strong believer in natural living as a way to improve health and prevent modern disease. She enjoys thinking outside of the box and challenging common myths about health and wellness. You can visit her blog to learn more:
www.livingthenourishedlife.com/2009…

Read the article here:  http://www.naturalnews.com/033778_shy_children_psychiatric_drugs.html

« Return to news items


Share

Online database lets you research the side effects of common psychiatric drugs

Thursday, September 15th, 2011

Natural News – September 15, 2011

by M.K. Tyler

(NaturalNews) If you have ever seen a commercial for a pharmaceutical drug, you are probably familiar with the long list of dangerous side effects that are rattled off in the last five seconds of the advertisement, just after viewers are told how Drug “X” is going to save their lives, improve their memories or give them unlimited energy. What was that? Did he just say that pill might cause bleeding out of my eyes?

Drug companies do a great job – and spend a lot of money – to ensure that most consumers aren’t aware of the harmful side effects of common drugs prescribed for conditions like depression, heart disease, arthritis, ADHD or high blood pressure. Unfortunately, the result of this has created a society where the average person with a health problem is captivated by the promises delivered in clever advertising. There is a drug for everything? All I have to do is talk to my doctor? How convenient.

But what if there was a way to take back control of our lives and our health? What if, despite talking to your doctor, you still have questions or concerns about the safety of a drug?

The Citizens Commission on Human Rights International (CCHR) has a database that allows you to do just that. It’s called the Psychiatric Drug Database, and it allows consumers to research the potential side effects of common psychiatric drugs, such as Ritalin or Wellbutrin.

While the database is limited to psychiatric drugs, this type of public information portal represents a significant step in the right direction to help patients find unbiased information and make informed decisions about their health.

The database allows you to search by drug and will retrieve information about adverse reactions reported by patients who have taken the drug, international warnings and studies that have been done on the drug and what side effects different age groups or genders have experienced. For example, a search of the effects of Ritalin on 18-30 year old women retrieved 89 reported cases of adverse side effects.

These effects including anxiety, fatigue, hypertension, tremors, chest discomfort, nausea, panic attacks, cardiac murmurs, aggression, suicide attempts and completed suicides. The results are broken down by case and list specific symptoms and reactions caused by the drug in each reported case.

Another search of Zoloft and its effects on young children included cases of cerebral disorders, upper respiratory tract infections, sleep disorders, vertigo, hallucinations, psychomotor hyperactivity and suicidal ideation.

The database only includes information on cases that were actually reported to the FDA’s Adverse Event Reporting System between 2004 and 2008. Based on the FDA’s own estimates, only about 1 to 10 percent of adverse drug side effects are even reported to the FDA. The CCHR’s database, therefore, represents only a small margin of the population that has been affected by adverse side effects of pharmaceutical psychiatric drugs.

Visitors to the site will also notice an interesting anecdote that describes how the definition of poison – a substance that causes death or harm when consumed by a living organism – clearly characterizes the drugs listed in the database. Consumers are encouraged to research potential problems of a drug before agreeing with their doctors to start a course of therapy.

To find more information about a particular drug, visit www.cchrint.org/psychdrugdangers

Sources for this article include

http://www.cchrint.org/psychdrugdan…

« Return to news items


Share

Ron Paul Reintroduces The Parental Consent Act 2011! Prohibits Federal Funding For Psychiatric ‘Screening’ of Kids

Tuesday, August 9th, 2011

Congressman Ron Paul has re-introduced  The Parental Consent Act ,  A bill which prohibits federal funds from being used to establish or implement any universal or mandatory mental health, psychiatric, or socioemotional screening program.

Click Video for more information on the Parental Consent Act

Sign the petition in support of the Parental Consent Act here: http://www.petitiononline.com/rppca/petition.html

Bill information:  The Parental Consent Act 2011 (H.R. 2769 – previously H.R. 2218  in 2009) Prohibits federal education funds from being used to pay any local educational agency or other instrument of government that uses the refusal of a parent or legal guardian to provide consent to mental health screening as the basis of a charge of child abuse, child neglect, medical neglect, or education neglect until the agency or instrument demonstrates that it is no longer using such refusal as a basis of such charge.

Defines a screening program under this Act as any mental health screening program in which a set of individuals is automatically screened without regard to whether there was a prior indication of a need for mental health treatment, including: (1) any program of state incentive grants to implement recommendations in the July 2003 report of the New Freedom Commission on Mental Health, the State Early Childhood Comprehensive System, grants for TeenScreen, and the Foundations for Learning Grants; and (2) any student mental health screening program that allows mental health screening of individuals under 18 years of age without the express, written, voluntary, informed consent of the parent or legal guardian of the individual involved.

Ron Paul speech given on April 30, 2009 on his bill, The Parental Consent Act (formerly H.R. 2218, now  reintroduced as H.R. 2769 ):

Madam Speaker, I rise to introduce the Parental Consent Act. This bill forbids Federal funds from being used for any universal or mandatory mental-health screening of students without the express, written, voluntary, informed consent of their parents or legal guardians. This bill protects the fundamental right of parents to direct and control the upbringing and education of their children.

The New Freedom Commission on Mental Health has recommended that the federal and state governments work toward the implementation of a comprehensive system of mental-health screening for all Americans. The commission recommends that universal or mandatory mental-health screening first be implemented in public schools as a prelude to expanding it to the general public. However, neither the commission’s report nor any related mental-health screening proposal requires parental consent before a child is subjected to mental-health screening. Federally-funded universal or mandatory mental-health screening in schools without parental consent could lead to labeling more children as “ADD” or “hyperactive” and thus force more children to take psychotropic drugs, such as Ritalin, against their parents’ wishes.

Already, too many children are suffering from being prescribed psychotropic drugs for nothing more than children’s typical rambunctious behavior. According to Medco Health Solutions, more than 2.2 million children are receiving more than one psychotropic drug at one time. In fact, according to Medico Trends, in 2003, total spending on psychiatric drugs for children exceeded spending on antibiotics or asthma medication.

Many children have suffered harmful side effects from using psychotropic drugs. Some of the possible side effects include mania, violence, dependence, and weight gain. Yet, parents are already being threatened with child abuse charges if they resist efforts to drug their children. Imagine how much easier it will be to drug children against their parents’ wishes if a federally-funded mental-health screener makes the recommendation.

Universal or mandatory mental-health screening could also provide a justification for stigmatizing children from families that support traditional values. Even the authors of mental-health diagnosis manuals admit that mental-health diagnoses are subjective and based on social constructions. Therefore, it is all too easy for a psychiatrist to label a person’s disagreement with the psychiatrist’s political beliefs a mental disorder. For example, a federally-funded school violence prevention program lists “intolerance” as a mental problem that may lead to school violence. Because “intolerance” is often a code word for believing in traditional values, children who share their parents’ values could be labeled as having mental problems and a risk of causing violence. If the mandatory mental-health screening program applies to adults, everyone who believes in traditional values could have his or her beliefs stigmatized as a sign of a mental disorder. Taxpayer dollars should not support programs that may label those who adhere to traditional values as having a “mental disorder.”

Madam Speaker, universal or mandatory mental-health screening threatens to undermine parents’ right to raise their children as the parents see fit. Forced mental-health screening could also endanger the health of children by leading to more children being improperly placed on psychotropic drugs, such as Ritalin, or stigmatized as “mentally ill” or a risk of causing violence because they adhere to traditional values. Congress has a responsibility to the nation’s parents and children to stop this from happening. I, therefore, urge my colleagues to cosponsor the Parental Consent Act.

For more information on the Parental Consent Act watch this video featuring Kent Snyder, Ron Paul’s Presidential campaign manager 2008, and former Executive Director of the Liberty Committee  http://www.cchrint.org/videos/experts/ron-pauls-parental-consent-act-of-2009/

« Return to news items


Share

Ritalin for children is “quick fix” and should be reviewed, demand educational psychologists

Wednesday, June 15th, 2011

Psychminded.co.uk
By Angela Hussain
June 15, 2011

Ritalin and other psychotropic medication for children are a “quick fix” and the government should urgently review their use, psychologists have urged.

The Association of Educational Psychologists (AEP) fears there is insufficient data on the effects such drugs have on child development. Further research is urgently needed, it says.

The AEP’s demand is despite the fact that a European Medicines Agency (EMA) investigation into methylphenidate drugs, which include psychotropics Ritalin, Concerta, Equasym, Medikinet and Rubifen – had previously stated that the benefits of such drugs outweigh any negative effects for children diagnosed with ADHD and other conduct disorders..

Plus, UK doctors have been advised by the National Institute for Health and Clinical Excellence not to prescribe methylphenidate as a first-line treatment for children diagnosed with ADHD.

But the AEP – which represents UK educational psychologists – fears there will be an increase of methylphenidate prescribing because the number of official psychological disorders for children is set to increase.

The American Psychiatric Association is working on its 2013 Diagnostic and Statistical Manual of Mental Disorders (the DSMV) in which additional psychological disorders for children are due to be added. These include Posttraumatic Stress Disorder in Preschool Children, Temper Dysregulation Disorder with Dysphoria, Callous and Unemotional Specifier for Conduct Disorder, Non-Suicidal Self Injury, and Non-Suicidal Self Injury Not Otherwise Specified.

“These could lead to more young people being referred for treatment with these [psychotropic] medications,” said Kate Fallon, AEP’s general secretary.

She said: “There is a danger that we rely on the ‘quick fix’ for children with conditions such as ADHD, which frequently means the prescription of medication such as Ritalin instead of a number of other possible interventions.”

Medicine regulators in European member states had in 2007 requested EMA’s mediation because of concerns over cardiovascular and cerebrovascular effects of methylphenidate – such as heart rate and blood pressure increases and heart attack.

A review was carried out by the EMA’s committee for medicinal products for human use. It was based on reported side effects and all studies on methylphenidate since the fifties.

The committee also investigated any link between methylphenidate and psychiatric problems, reduced growth and sexual maturation.

An urgent restriction to methylphenidate prescribing was not needed, the committee concluded.

http://psychminded.co.uk/news/news2011/june11/Ritalin-for-children-is-quick-fix-and-should-be-reviewed-demand-educational-psychologists001.html

« Return to news items


Share

Seroquel Marketing Undeterred by Deceptive-Marketing Settlement

Monday, April 11th, 2011

The Epoch Times – April 11, 2011

by Martha Rosenberg

AstraZeneca has already settled nearly 25,000 personal-injury lawsuits pertaining to its antipsychotic drug Seroquel

Google the word “depression” and the first search result you’ll get will be for the antipsychotic drug Seroquel XR.

Visit WebMD and you’ll find the home page hosts similar ads for Seroquel XR, above and adjacent to the lead news story.

Who would know that AstraZeneca inked the largest multi-state consumer-protection settlement on record relating to deceptive Seroquel marketing on March 14 for $68.5 million? And only a year after inking a similar settlement related to burying side effect and safety information for $520 million with the government!

Who would know AstraZeneca has already settled nearly 25,000 personal-injury lawsuits pertaining to Seroquel, with more to come, says ABC News?

First approved in 1997, Seroquel has enjoyed the camel-nose-under-the-tent phenomenon known as indications creep. First approved for schizophrenia, it was later approved for bipolar disorder and psychiatric conditions in children.

But it was Seroquel’s 2009 approval as a drug for depression that helped it reach its spectacular sales of $5.3 billion in 2010 thanks to the United States’ walloping depression “market” of 20 million depression sufferers.

Seroquel’s blood sugar, weight gain, and heart side effects are well-known. That’s why FDA regulators opposed its use as a first-choice, stand-alone treatment for the 10 percent of the U.S. population with depression when safer drugs exist.

“I saw no clear advantage demonstrated in efficacy,” said Dr. Wayne Goodman, who chaired the FDA panel considering the depression indication. “There were side effects, and I would expect unintended consequences associated with wide-scale use of the drug.”

The drug also can cause increased mortality in elderly patients with dementia-related psychosis, suicide, neuroleptic malignant syndrome, cataracts, seizures, increase in blood pressure, and movement disorders in neonates when their mothers take it.

Seroquel’s fraud trail is also well-known, with more than six conflict-of-interest scandals swirling around Seroquel researchers and promoters. Psychiatrist Richard Borison was sentenced to a 15-year prison sentence in 1998 for a pay-to-play Seroquel research scheme, which helped establish Seroquel’s original perception as being safe.

But how many realize Seroquel’s cost to the individual taxpayer and health insurance consumers at a red-book price of almost $500 per month per person?

Auditors with the Michigan Corrections Department say the state could save $350,000 a month by switching just half of its Seroquel prescriptions to another pill. North Carolina spends $29.4 million per year on Seroquel prescriptions. Who knows how much more states and taxpayers are paying to control the metabolic side effects that emerge from taking Seroquel?

Reports are also starting to surface about the effects $6,000-a-year Seroquel prescriptions are having on rising insurance premiums for private insurance holders.

In fact, the public is really paying twice for irrepressible Seroquel marketing: first, for drug purchases by state and private plans, and, second, in suffering the drug’s side effects.

Martha Rosenberg is a freelance writer who lives in Chicago.

http://www.theepochtimes.com/n2/health/seroquel-marketing-undeterred-by-deceptive-marketing-settlement-54506.html

« Return to news items


Share